These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20839285)

  • 1. Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.
    Leslie WD; Lix LM;
    J Bone Miner Res; 2011 Mar; 26(3):460-7. PubMed ID: 20839285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
    Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
    J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imputation of 10-year osteoporotic fracture rates from hip fractures: a clinical validation study.
    Leslie WD; Lix LM;
    J Bone Miner Res; 2010 Feb; 25(2):388-92. PubMed ID: 19653809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-site vs multisite bone density measurement for fracture prediction.
    Leslie WD; Lix LM; Tsang JF; Caetano PA;
    Arch Intern Med; 2007 Aug 13-27; 167(15):1641-7. PubMed ID: 17698687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Lix LM
    Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement.
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):839-47. PubMed ID: 20959961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The fracture risk assessment tool (FRAXTM), where are we in Tunisia?].
    Zrour-Hassen S; Jguirim M; Guezguez M; Mnif H; Younes M; Bejia I; Touzi M; Abid A; Essabah H; Bergaoui N
    Tunis Med; 2011 Feb; 89(2):136-41. PubMed ID: 21308620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
    Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
    Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture prediction from bone mineral density in Japanese men and women.
    Fujiwara S; Kasagi F; Masunari N; Naito K; Suzuki G; Fukunaga M
    J Bone Miner Res; 2003 Aug; 18(8):1547-53. PubMed ID: 12929946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    J Bone Miner Res; 2010 Nov; 25(11):2350-8. PubMed ID: 20499367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonstandard Lumbar Region in Predicting Fracture Risk.
    Alajlouni D; Bliuc D; Tran T; Pocock N; Nguyen TV; Eisman JA; Center JR
    J Clin Densitom; 2018; 21(2):220-226. PubMed ID: 28689879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
    Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
    J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.
    Leslie WD; Morin SN; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):85. PubMed ID: 32514615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures.
    Giangregorio LM; Leslie WD;
    J Bone Miner Res; 2010 Jun; 25(6):1400-5. PubMed ID: 20200950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study.
    Schoofs MW; van der Klift M; Hofman A; van Duijn CM; Stricker BH; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2004 Sep; 19(9):1490-6. PubMed ID: 15312249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
    MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
    J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of osteoporotic sites and fracture risk assessment: a cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Caetano PA; Lix LM;
    J Bone Miner Res; 2007 Mar; 22(3):476-83. PubMed ID: 17144788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified 10-year absolute fracture risk assessment: a comparison of men and women.
    Leslie WD; Lix LM;
    J Clin Densitom; 2010; 13(2):141-6. PubMed ID: 20435264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.